Defective Mitophagy and the Etiopathogenesis of Alzheimer's Disease
Overview
Affiliations
Accumulation of impaired mitochondria and energy metabolism disorders are non-negligible features of both aging and age-related neurodegeneration, including Alzheimer's disease (AD). A growing number of studies suggest that mitophagy disorders play an important role in AD occurrence and development. The interaction between mitophagy deficits and Aβ or Tau pathology may form a vicious cycle and cause neuronal damage and death. Elucidating the molecular mechanism of mitophagy and its role in AD may provide insights into the etiology and mechanisms of AD. Defective mitophagy is a potential target for AD prevention and treatment.
Singh S, Singh R Mol Biol Rep. 2025; 52(1):173.
PMID: 39880979 DOI: 10.1007/s11033-025-10297-6.
Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies.
Wang S, Liao Z, Zhang Q, Han X, Liu C, Wang J Front Immunol. 2025; 15:1484373.
PMID: 39877373 PMC: 11772192. DOI: 10.3389/fimmu.2024.1484373.
Tau phosphorylation suppresses oxidative stress-induced mitophagy via FKBP8 receptor modulation.
Isei M, Crockett M, Chen E, Rodwell-Bullock J, Carroll T, Girardi P PLoS One. 2025; 20(1):e0307358.
PMID: 39752365 PMC: 11698316. DOI: 10.1371/journal.pone.0307358.
Ye K, Zhao X, Liu L, Ge F, Zheng F, Liu Z Mol Neurobiol. 2024; .
PMID: 39710824 DOI: 10.1007/s12035-024-04642-2.
Mitochondrial Quality Control in Alzheimer's Disease: Insights from Models.
Ganguly U, Carroll T, Nehrke K, Johnson G Antioxidants (Basel). 2024; 13(11).
PMID: 39594485 PMC: 11590956. DOI: 10.3390/antiox13111343.